AHA today urged the Antitrust Division of the Department of Justice to investigate thoroughly Centene's proposed acquisition of WellCare “because it threatens to reduce competition in delivery of Medicaid managed care and Medicare Advantage services to tens of millions of consumers across broad swaths of the country.” The letter notes, “There is no service more important to American consumers than health care, and vigorous competition among health insurance companies is necessary to ensure that consumers receive high quality at affordable rates. The facts show that the WellCare-Centene transaction is likely to significantly reduce competition and will therefore harm the most vulnerable Americans. DOJ should vigorously review this transaction's effects on current and future competition and take all appropriate measures to protect U.S. consumers.”

Related News Articles

Headline
A report released Jan. 9 by Kaufman Hall highlights hospital and health system merger and acquisition activity from last year.  The report said that…
Chairperson's File
From making pizzas to leading an integrated health system, Tina Freese Decker’s career has focused on a connection to people and serving others. She is…
Headline
The U.S. Chamber of Commerce Jan. 13 filed a lawsuit against the Federal Trade Commission, saying changes made by the FTC to premerger notification rules under…
Headline
The Federal Trade Commission Oct. 10 finalized changes to the premerger notification rules, form and instructions under the Hart-Scott-Rodino Antitrust…
Headline
The AHA's Institute for Diversity and Health Equity has extended until Oct. 15 the deadline to apply for the 2025 Carolyn Boone Lewis Equity of Care Awards,…
Headline
Main Line Health’s strategic collection and utilization of data, as well as its initiatives to improve the health of communities of color, earned the health…